Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Huanglianejiao capsule for chronic primary insomnia
ChiCTR-IPR-15007222Phase 3Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Aug 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Huanglianejiao capsule in primary insomnia (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Total Sleep Time (Subjective). Started Aug 2014; status: recruiting.
02
Drugs
Huanglianejiao capsule
03
Conditions
primary insomnia
Beyond the preview
Go deeper on ChiCTR-IPR-15007222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007222.